TKMDIP-1
 
		Product Description
CAT No.
				
									ALN-T023084								
				CAS No.
				
									2518331-26-3								
				Mol. F.
				
									C7H8ClN3O2S								
				Mol. Wt.
				
									233.7								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 4-Chloro-5-nitro-2-(propylthio)pyrimidine								
				
									Smiles : ClC1=C([N+]([O-])=O)C=NC(SCCC)=N1								
				
									Inchi : InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15-,16+,17-,19-,20+/m1/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
									By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.								
				Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
									By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724 								
				Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
									By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            